Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

The biotech startup Inscripta is attempting to “democratize” CRISPR by offering it to select researchers at no cost, according to Fortune. Here are four things to know about the startup’s business ...

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed ...

Verve Therapeutics, a Cambridge, Mass.-based startup that plans to use gene editing technology to treat heart disease, announced its official launch and $58.5 million in Series A financing on May 7.

CRISPR Therapeutics and Vertex Pharmaceuticals are partners in one particular program, and they recently won approval for the gene-editing treatment Casgevy. Beyond Casgevy, Vertex has a ...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of technology. Crypto billionaire Brian Armstrong is ready to invest in ...

With $80 million in funding from a list of high-profile backers, the startup is developing bifunctional antibodies that drag ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Oct 7, 2020, 10:38am EDT Updated: Oct 7, 2020, 11:06am EDT Spencer A. Brown FILE — CRISPR gene-editing technology inventor Jennifer Doudna of the University of California, Berkeley, accepts the Life ...